Effect of age on CD4+ cells regeneration in patients with hiv infection undergoing triple antiretroviral therapy
Benetucci, J.; Carlevaro, R.én.; Diez, M.ía.S.; Thwaites, A.; Cappello, S.; Garone, D.; Montero, A.
Medicina 62(1): 105-106
2002
ISSN/ISBN: 0025-7680 PMID: 11965843 Document Number: 540716
Document emailed within 1 workday
Related Documents
Hoffmann, F.; Funk, M.; Linde, R.; Notheis, G.; Petropoulou, T.; Eberle, J.; Gürtler, L.; Belohradsky, B.H.; Wintergerst, U. 2002: Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection European Journal of Medical Research 7(7): 330-3342001: Acceptance of antiretroviral therapy. HIV-infected patients assess convenient triple combination MMWFortschrittederMedizin 143(35-36): 56
Iurin, O.G. 2007: Indications for initiation of antiretroviral therapy in patients with HIV infection. Choice of first-line drugs and schemes of therapy Terapevticheskii Arkhiv 79(11): 67-69
Sternfeld, T.; Schmid, M.; Tischleder, A.; Mudra, S.; Schlamp, A.; Kost, B.P.; Gruber, R.; Youle, M.; Bogner, J.R.; Goebel, F.-D. 2007: The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells Antiviral Therapy 12(5): 769-778
Siennicka, J.; Durlik, M.; Litwińska, B.; Chmura, A.; Lewandowska, D.; Lao, M.; Paczek, L.; Kańtoch, M. 1999: Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment Acta Microbiologica Polonica 48(1): 61-71
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Mathez, D.; Bagnarelli, P.; Gorin, I.; Katlama, C.; Pialoux, G.; Saimot, G.; Tubiana, P.; De Truchis, P.; Chauvin, J.P.; Mills, R.; Rode, R.; Clementi, M.; Leibowitch, J. 1997: Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy Antiviral Therapy 2(3): 175-183
Thuret, I. 2004: Infection à VIH de l'enfant : quand débuter le traitement antirétroviral ? - When to initiate antiretroviral therapy in HIV-infected children? Archives de Pediatrie (Paris) 11(12): 1521-1524
McMenamin, J.; Allardice, G.; Goldberg, D.; Parpia, T.; Raab, G.; Parpira, T. 1998: Antiretroviral combination therapy and HIV infection. Such treatment improved CD4 counts in Scottish patients Bmj 317(7162): 887
Pinheiro Neto, C.D.óg.; Weber, R.; Araújo-Filho, B.C.; Miziara, I.D. 2009: Rhinosinusitis in HIV-infected children undergoing antiretroviral therapy Brazilian Journal of Otorhinolaryngology 75(1): 70-75
Sharma, S.; Khadga, P.; Dhungana, G.P.; Chitrakar, U. 2013: Medication adherence to antiretroviral therapy among patients visiting antiretroviral therapy center at Tribhuvan University Teaching Hospital, Kathmandu Nepal Kathmandu University Medical Journal 11(41): 50-53
Jáuregui Camargo, L.; Ruiz-Palacios, G.; Guerrero Almeida, L.; Niño Oberto, S.; Peasey, A.; Sierra Madero, J. 2003: Evaluation of highly active antiretroviral therapy (HAART) in a cohort of patients with HIV infection in Mexico Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(1): 10-17
Holm, M.R.; Hansen, B.R.øn.; Røder, M.E. 2006: Diabetic ketoacidosis in an HIV-infected patient undergoing antiretroviral therapy Ugeskrift for Laeger 168(9): 920-921
Schwenk, A.; Beisenherz, A.; Kremer, G.; Diehl, V.; Salzberger, B.; Fätkenheuer, G. 1999: Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment American Journal of Clinical Nutrition 70(5): 867-873
Souza Junior, P.R.B.d.; Szwarcwald, C.él.L.; Castilho, E.A.d. 2011: Self-rated health by HIV-infected individuals undergoing antiretroviral therapy in Brazil Cadernos de Saude Publica 27(Suppl 1): S56-S66
Pal, J.; Sen, K.; Sarkar, G.; Mandal, A.; Chakraborty, S.; Deb, A. 2013: Effect of antiretroviral therapy on pulmonary hypertension in HIV patients Journal of the Indian Medical Association 111(12): 845
Da Silva, C.A.L.; Dourado, I.ês.; Dahia, S.R.; Harzheim, E.; Rutherford, G.W. 2008: Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil Journal of Public Health Dentistry 68(3): 178-181
Almeida, E.A.; Lima, Jé.N.; Lages-Silva, E.; Guariento, M.E.; Aoki, F.H.; Torres-Morales, A.E.; Pedro, Rério.J. 2010: Chagas' disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history Transactions of the Royal Society of Tropical Medicine and Hygiene 104(7): 447-452
Rosen, S.; Larson, B.; Rohr, J.; Sanne, I.; Mongwenyana, C.; Brennan, A.T.; Galárraga, O. 2014: Effect of antiretroviral therapy on patients' economic well being: five-year follow-up Aids 28(3): 417-424